Issue 006 | U.S. Pilot | US

TENX

TENAX THERAPEUTICS, INC.

Screen state: Passing Source state: Verified 10-Q | 2026-05-12 Filing currency: USD
Internal NCAV Discount 61.9%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
123,178,000USD
Total Liabilities
8,486,000USD
NCAV
114,692,000USD
Cash
118,800,000USD
NCAV per share
4.32USD/share
Evidence
10 annual | 20 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Evaluated
12
Triggered
2
Unavailable
7
Requires inspection Negative OCF -9,309,000
Latest
-9,309,0002026-03-31
Comparison
n/a
Change
n/a

Basis: latest reporting-period cash from operations < 0

Source periods: SEC 10-Q 2026-03-31 · 0001193125-26-219383

Supporting observation Current Ratio > 1.5 14.52
Latest
14.522026-03-31
Comparison
1.5
Change
n/a

Basis: current assets / current liabilities; strong if > 1.5

Source periods: SEC 10-Q 2026-03-31 · 0001193125-26-219383

7 unavailable checks — inspect missing inputs
High Debt (short-term debt + long-term debt) / ordinary equity >= 50%
Low Debt (short-term debt + long-term debt) / ordinary equity < 20%
Material 1Y Share Increase 1Y share change >= +2% using the same share-count source
NCAV Growing equivalent prior-year NCAV change >= +2%; both NCAV values must be positive
No Material 1Y Share Increase 1Y share change > -2% and <= +1% using the same share-count source
Non-Positive Equity ordinary shareholders equity <= 0
Share Count Reduced 1Y share change <= -2% using the same share-count source

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Share Count & Per-Share Comparability

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: verified

Display basis

Verified split events: reverse 20.0 on 2013-05-10; reverse 20.0 on 2018-12-31; reverse 20.0 on 2023-01-04; reverse 80.0 on 2024-01-02

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
2020-12-31
10-K
USD
2019-12-31
10-K
USD
2018-12-31
10-K
USD
2017-12-31
10-K
USD
2016-12-31
10-K
USD
Revenue 0 0 n/a n/a n/a n/a n/a n/a n/a 0
Operating Income -56,385,000 -19,494,000 8,233,941 -11,052,643 32,728,241 -9,867,930 -8,555,264 -6,893,280 -9,205,898 -52,650,739
Net Income -52,599,000 -17,602,000 7,710,673 -11,047,895 -32,474,358 -9,851,391 -8,394,363 -14,144,049 -8,839,682 -43,923,904
Cash From Operations -35,800,000 -14,811,000 -5,903,532 -12,012,873 -10,856,203 -9,272,856 -7,556,177 -5,499,461 -12,140,517 -15,871,300
Capex n/a n/a n/a -2,323 -5,252 -3,490 -3,574 -7,595 -4,537 -2,884
Free Cash Flow n/a n/a n/a -12,015,196 -10,861,455 -9,276,346 -7,559,751 -5,507,056 -12,145,054 -15,874,184
Cash And Equivalents 97,600,000 94,900,000 9,800,000 2,123,682 5,583,922 6,250,241 4,905,993 12,367,321 1,604,810 9,995,955
Accounts Receivable n/a n/a n/a n/a n/a n/a n/a 0 50,171 72,599
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets 104,227,000 96,686,000 11,683,510 3,208,465 5,689,000 6,795,506 6,180,829 13,320,240 8,062,893 13,628,175
Total Assets 104,227,000 96,686,000 11,684,627 3,404,709 5,992,235 6,868,691 6,365,271 13,337,200 9,890,701 23,340,175
Total Current Liabilities 7,156,000 4,693,000 3,586,520 1,847,772 1,563,978 2,118,963 2,532,395 1,565,669 1,008,840 6,199,237
Total Liabilities 7,156,000 4,693,000 3,586,520 1,911,968 1,747,567 2,243,129 2,592,774 1,565,669 1,008,840 6,199,237
Shareholders Equity 97,071,000 91,993,000 8,098,107 1,492,741 4,244,668 4,625,562 3,772,497 11,771,531 8,881,861 17,140,938
Shares Outstanding 17,197,613 3,970,385 298,281 28,648 15,754 9,356 4,755 3,847 45 879
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 39,217,244 15,271,705 248,447 n/a 12,861 6,479 3,872 978 44 879
Weighted Avg Shares Basic 39,217,244 15,271,705 248,447 n/a 12,861 6,479 3,872 978 44 879
Net Share Count Change (Normalized) 57.7% 0.4% 0.0% 52.9% 0.0% 87.2% 77.8% 5272.1% -95.0% Insufficient evidence
Ownership Claim Change (Normalized) -36.6% -0.4% -0.0% -34.6% -0.0% -46.6% -43.8% -98.1% 1891.7% Insufficient evidence
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-12-31
10-K
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
Revenue 0 0 0 0 0 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -16,573,000 -16,449,000 -16,806,000 -11,792,000 -11,338,000 -23,876,576 4,618,881 3,672,021 -3,908,326 3,340,937 2,117,379 1,236,160 1,539,465 -19,550,662 2,917,488 2,861,892 2,718,639 3,211,789 3,802,290 1,964,500
Net Income -15,716,000 -15,540,000 -15,804,000 -10,847,000 -10,408,000 -28,936,982 3,960,469 3,575,673 3,798,840 5,438,276 1,971,975 -1,106,338 1,406,760 -14,103,917 2,916,537 2,861,021 -2,721,536 -61,738,162 3,798,648 1,717,016
Cash From Operations -9,309,000 -13,415,000 -9,155,000 -6,263,000 -6,967,000 -3,527,033 -3,087,298 -3,030,669 -5,166,000 -1,174,540 -2,081,154 -922,966 -1,724,872 -2,313,082 -3,330,905 -3,431,209 -2,937,677 -2,768,455 -3,021,509 -1,845,098
Capex n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1,602 -1,241 4,000 0 0 -6,323 -1,698 -1,679 -1,875
Free Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -924,568 -1,726,113 -2,309,082 -3,330,905 -3,431,209 -2,944,000 -2,770,153 -3,023,188 -1,846,973
Cash And Equivalents 118,800,000 97,600,000 99,400,000 105,500,000 111,400,000 94,900,000 98,310,918 9,384,015 12,549,475 9,800,000 11,141,136 13,393,573 14,414,844 2,123,682 3,806,399 7,229,179 2,868,684 5,583,922 8,354,075 1,671,422
Total Current Assets 123,178,000 104,227,000 102,810,000 105,857,000 112,059,000 96,686,000 99,783,628 10,615,792 14,459,147 11,683,510 11,883,086 14,038,707 15,264,825 3,208,465 4,513,593 8,101,542 3,455,671 5,689,000 8,583,227 2,532,227
Total Liabilities 8,486,000 7,156,000 6,599,000 2,527,000 2,768,000 4,693,000 2,561,690 1,740,837 2,030,579 3,586,520 602,214 823,841 989,301 1,911,968 785,169 1,571,681 2,131,418 1,747,567 1,672,951 1,414,049
Shares Outstanding 26,525,159 17,197,613 6,243,575 4,562,500 4,148,495 3,970,385 3,408,906 1,958,245 1,958,245 298,281 298,280 298,280 272,218 28,648 18,738 15,754 15,754 15,754 15,754 15,751
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 45,226,328 40,917,109 39,741,404 39,572,177 36,584,920 36,450,836 21,161,143 1,958,245 1,219,139 248,447 n/a n/a n/a n/a n/a n/a n/a 15,754 15,751 10,761
Weighted Avg Shares Basic 45,226,328 40,917,109 39,741,404 39,572,177 36,584,920 36,450,836 21,161,143 1,958,245 1,219,139 248,447 n/a n/a n/a n/a n/a n/a n/a 15,754 15,751 10,761
Net Share Count Change (Normalized) 160.6% 57.7% 42.4% 4.5% 16.1% 0.4% 74.1% 0.0% 556.5% 0.0% 0.0% 9.6% 850.2% 52.9% 18.9% 0.0% 0.0% 0.0% -0.0% 99.8%
Ownership Claim Change (Normalized) -61.6% -36.6% -29.8% -4.3% -13.8% -0.4% -42.6% 0.0% -84.8% -0.0% 0.0% -8.7% -89.5% -34.6% -15.9% 0.0% 0.0% -0.0% 0.0% -49.9%
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 123,178,000USD us-gaap:AssetsCurrent 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0000034956/companyfacts.json
Data Vault | sec/companyfacts/cik=0000034956/companyfacts.json
Total Liabilities 8,486,000USD us-gaap:Liabilities 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0000034956/companyfacts.json
Data Vault | sec/companyfacts/cik=0000034956/companyfacts.json
Cash 118,800,000USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0000034956/companyfacts.json
Data Vault | sec/companyfacts/cik=0000034956/companyfacts.json
Shares Outstanding 26,525,159 dei:EntityCommonStockSharesOutstanding 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0000034956/companyfacts.json
Data Vault | sec/companyfacts/cik=0000034956/companyfacts.json
NCAV 114,692,000USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 4.32USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 61.9% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
Local evidence | The Data Vault
CIK
0000034956
Company ID
n/a
Selected Annual Source
Data Vault | sec/companyfacts/cik=0000034956/companyfacts.json
Selected Quarterly Source
Data Vault | sec/companyfacts/cik=0000034956/companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
26
Imported At
2026-08-15T12:52:54+00:00
Rendered At
2026-08-16T03:30:06+00:00

Run Audit

Mary Run
63eb9cbe01c34796bb5a9e8d156e6111
Mary As Of
2026-08-15
Accession
0001193125-26-219383
CIK
0000034956
Mary Filing Date
2026-05-12
Filing Currency
USD
Internal Discount
61.9%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=63eb9cbe01c34796bb5a9e8d156e6111; mary_as_of=2026-08-15; mary_filing_date=2026-05-12; mary_accession=0001193125-26-219383; mary_cik=0000034956; gnni_supporting_filing_date=2026-05-12; internal_discount=0.619015; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive